Obsessive Compulsive DisorderNCT01506206
ON/OFF Stimulation and Impulsivity in Patients With Deep Brain Stimulators
An observational study of Obsessive Compulsive Disorder and Major Depressive Disorder, run by Massachusetts General Hospital at 2 sites in United States.
Trial summary
The investigators propose a test of causality by examining a cohort of patients undergoing deep brain stimulation (DBS) within the ventral striatum. The investigators will examine behavior on and off stimulation across a range of tasks that index different forms of impulsivity. Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Obsessive Compulsive Disorder, Major Depressive Disorder
- How many people
- 0 participants
- Where
- 2 sitesUnited States
- Study dates
- Feb 2012to 10 Jan 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with Deep Brain Stimulators Patients with Major Depressive Disorder or Obsessive-Compulsive Disorder and no DBS
Who may be able to join
- Deep brain stimulator implantation performed at least three months prior to study
- Right-handed (as determined by the Handedness Inventory; Oldfield, 1971)
- Normal or corrected-to normal vision and hearing
- Current diagnosis of MDD or OCD
Who cannot join
- Subjects unable to visualize stimulus objects with correction
- Dementia or other known cognitive deficit
- Psychiatric Patients:
- Clinical history of bipolar disorder
- Current or past psychotic disorder
- Gross structural brain damage
Show all 11Show fewer
- Cognitive impairment that would affect a participant's ability to give informed consent
- Current substance abuse, or abuse within the past 3 months
- Clinical history of severe personality disorder
- Imminent risk of suicide or an inability to control suicide attempts
- Evidence of dementia or other significant cognitive impairment on neuropsychological evaluation
Trial locations and contacts
2 sites in 1 country.
United States2 sites
Massachusetts General Hospital
Boston, Massachusetts, 02114
Massachusetts General Hospital
Charlestown, Massachusetts, 02129
About this study
The investigators propose a test of causality by examining a cohort of patients undergoing deep brain stimulation (DBS) within the ventral striatum. The investigators will examine behavior on and off stimulation across a range of tasks that index different forms of impulsivity. Patients will be studied in both the ON and OFF state - that is, they will be tested during active deep brain stimulation and 30 min to 1 hour after stimulation has been stopped (order of state will be counterbalanced across subjects). The investigators specific aim is to test the hypothesis that enhancing ventral striatal signaling (i.e. ON-state DBS) will cause more impulsive patterns of behavior across several impulsivity tasks. The investigators predict that ventral striatal DBS will increase stop-signal reaction time on the stop-signal task and commission errors on the Go/NoGo task, and increase delay aversion in a delay discounting paradigm.
Read the detailed description
The study will take place at a clinical office in the Charlestown Navy Yard (CNY), and will consist of 4 or 4.5 hour visit. Study staff will schedule a convenient time for patients to arrive, or the research visit may be paired with a regularly scheduled DBS programming visit. A member of the Division of Neurotherapeutics authorized to manipulate DBS programming will turn the device ON and OFF during the study. The subject's therapeutic parameters of the DBS system will not be changed. The subject will be asked to complete 2 questionnaires. Following these questionnaires, DBS stimulation will be turned off and a member of the study staff will teach the subjects to perform the following tasks on the computer:
Stop-Signal Task To measure "impulsive action," the investigators will use the stop-signal task (SST), a well-validated measure of response inhibition known to be impaired in substance abusers. In each of the 192 trials (3 blocks of 64; 10s interval between blocks, 2s ISI), subjects see a fixation cue (250ms) that is replaced by a shape (square or circle). Participants are told to make a shape judgment by pressing the appropriate computer key. On no-signal trials (75%), subjects are instructed to respond to the stimulus as fast and accurately as possible. On stop-signal trials (25%), the stimulus is followed by an auditory stop signal, and subjects are instructed to withhold responding. On stop-signal trials, a stop signal is presented after a variable delay (SSD), initially set at 250 msec and adjusted continuously with a staircase procedure by 50ms depending on whether inhibition is successful (increases) or unsuccessful (decreases). The paradigm will be administered using precompiled software provided by Gordon Logan, which automatically analyzes all relevant dependent variables (e.g stop-signal reaction time [SSRT] and GoRT). This task takes approximately 20 minutes.
Rewarded Variant This task is a variant of the above, with an inclusion of a "points possible cue" (2 or 50 points) for 500 ms, and followed by a brief delay (500-1500 ms) prior to the target. The task will be presented in 13 blocks. The first contains only go trials, from which the initial SSD will be calculated. The 12 subsequent blocks each consist of 40 trials; 18 standard go trials, 12 high reward (HR) go trials, 6 standard stop trials, and 4 HR stop trials, presented in random order. The SSD will be determined by a simple staircase-tracking algorithm as described by Logan, in which the SSD is adjusted up or down by 25 ms in order to establish an SSD that produces 50% accuracy of successful performance, with separate staircases calculated for the HR and standard trials. Outcome measures are the standard and high reward GoRTs, the standard and HR SSRTs, and the proportion of responses that would have been unsuccessfully stopped on HR trials if the standard SSD were utilized instead of the HR SSD.
Rewarded Go/NoGo Task In this task, participants are asked to make, or withhold, a button press to one of six stimuli (shapes), that correspond to six trial types: Go (no reward), Go (low reward), Go (high reward), NoGo (no reward), NoGo (low reward), NoGo (high reward). Participants are asked to press a button for Go stimuli and withhold a button press for NoGo stimuli. The ratio of Go stimuli to NoGo stimuli is approximately 15:1. Participants win money for correctly pressing a button for Go stimuli and for withholding a response for NoGo stimuli; conversely, they lose money for failing to respond to a Go stimuli or for failing to withhold a response to NoGo stimuli. There are 1260 trials, and each lasts 1 second. The task takes about 20 minutes to complete. Task may be administered without reward contingencies. In this case, there will only be two trial types: Go and NoGo.
Delay Discounting Task To measure "impulsive choice" the investigators will use a delay-discounting (DD) paradigm101. On each trial, participants make a binary choice between a smaller/sooner and a larger/later reward. The delay of the sooner reward is set as today, 2 weeks, \& 1 month; the delay of the later reward ranges from 2 to 6 weeks after the early reward. The sooner reward is from 1% to 50% less than the late reward (max = $40). Participants will complete approximately 80 trials. Participants are told that two of their choices will be randomly selected for payout at the appropriate time. Outcome variables include the proportion of choices for immediate/sooner rewards, as well as discounting parameter k, obtained by fitting choice data for each subject to a hyperbolic discount function. The task takes approximately 15 minutes to complete.
30 minutes after turning OFF DBS stimulation, participants will either remain in the OFF condition or will have the DBS turned ON, depending on their counter-balanced condition assignment. Subjects will complete the tasks above in the first condition. Following task completion, subjects will have DBS stimulation turned OFF or ON (again, depending on condition assignment). After 30 minutes, participants will complete the same tasks in the second condition. Following retesting, participants that were in the OFF condition will return to ON DBS stimulation.
The investigators will be using the implanted pulse generator to deliver a safe current. Because the investigators are not changing the therapeutic parameters of stimulation, subjects should not experience any changes during the ON condition. Should any discomfort arise in the OFF condition, the subject will be able to terminate the study and return to the ON condition immediately. The computer will register the subject's performance.
Electroencephalography recordings (EEG) will be acquired during performance of the aforementioned tasks. Continuous EEG data will be sampled at a maximum of 1024Hz using a 64-electrode cap. Eye movement artifacts will be assessed using bipolar electrodes.
Patients with just major depressive disorder or obsessive compulsive disorder will also be recruited as a control group for the patients with deep brain stimulation.
- Keywords
- Deep Brain Stimulation, Impulsivity
- Medical subject headings
- Obsessive-Compulsive Disorder, Depressive Disorder, Major, Impulsive Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Patients with Deep Brain Stimulators | Patients with deep brain stimulation for either major depressive disorder (MDD) or obsessive compulsive disorder (OCD). | |
| Patients with MDD or OCD | Patients with MDD or OCD who do not have a deep brain stimulator. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Impulsive Action
As measured by the Go/No Go task
Measured: 2 hours
Secondary outcomes (1)
Impulsive Choice
As measured by delayed discounting task
Measured: 2 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jan 2012 (estimated)
- Study startFeb 2012
- Primary completion10 Jan 2024
- Study completion10 Jan 2024
Why it stopped: Study was not funded and never enrolled participants.
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Obsessive Compulsive DisorderStudies of the same condition, open and under way.
- More trials run by Massachusetts General HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Massachusetts General Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Darin Dougherty, MD, Massachusetts General Hospital
- Investigators
- Darin D Dougherty, MD, Principal investigator, Massachusetts General Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01506206
- Sponsor's protocol ID
- 2011P002546
- Status last verified
- Jan 2024
- First submitted
- 5 Jan 2012
- Last updated
- 23 Jan 2024
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 Jan 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- ON/OFF Stimulation and Impulsivity in Patients With Deep Brain Stimulators
- ClinicalTrials.gov ID
- NCT01506206
- Acronym / sponsor ID
- 2011P002546
- Keywords
- Deep Brain Stimulation, Impulsivity
- Study type
- Observational
- Recruitment status
- WithdrawnReason stopped: Study was not funded and never enrolled participants.
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Massachusetts General HospitalUniversity, hospital or other
- Study start
- Feb 2012
- Primary completion
- 10 Jan 2024 (actual)
- Study completion
- 10 Jan 2024 (actual)
- First posted
- 9 Jan 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The investigators propose a test of causality by examining a cohort of patients undergoing deep brain stimulation (DBS) within the ventral striatum. The investigators will examine behavior on and off stimulation across a range of tasks that index different forms of impulsivity. Patients will be studied in both the ON and OFF state - that is, they will be tested during active deep brain stimulation and 30 min to 1 hour after stimulation has been stopped (order of state will be counterbalanced across subjects). The investigators specific aim is to test the hypothesis that enhancing ventral striatal signaling (i.e. ON-state DBS) will cause more impulsive patterns of behavior across several impulsivity tasks. The investigators predict that ventral striatal DBS will increase stop-signal reaction time on the stop-signal task and commission errors on the Go/NoGo task, and increase delay aversion in a delay discounting paradigm.
Detailed description
The study will take place at a clinical office in the Charlestown Navy Yard (CNY), and will consist of 4 or 4.5 hour visit. Study staff will schedule a convenient time for patients to arrive, or the research visit may be paired with a regularly scheduled DBS programming visit. A member of the Division of Neurotherapeutics authorized to manipulate DBS programming will turn the device ON and OFF during the study. The subject's therapeutic parameters of the DBS system will not be changed. The subject will be asked to complete 2 questionnaires. Following these questionnaires, DBS stimulation will be turned off and a member of the study staff will teach the subjects to perform the following tasks on the computer:
Stop-Signal Task To measure "impulsive action," the investigators will use the stop-signal task (SST), a well-validated measure of response inhibition known to be impaired in substance abusers. In each of the 192 trials (3 blocks of 64; 10s interval between blocks, 2s ISI), subjects see a fixation cue (250ms) that is replaced by a shape (square or circle). Participants are told to make a shape judgment by pressing the appropriate computer key. On no-signal trials (75%), subjects are instructed to respond to the stimulus as fast and accurately as possible. On stop-signal trials (25%), the stimulus is followed by an auditory stop signal, and subjects are instructed to withhold responding. On stop-signal trials, a stop signal is presented after a variable delay (SSD), initially set at 250 msec and adjusted continuously with a staircase procedure by 50ms depending on whether inhibition is successful (increases) or unsuccessful (decreases). The paradigm will be administered using precompiled software provided by Gordon Logan, which automatically analyzes all relevant dependent variables (e.g stop-signal reaction time [SSRT] and GoRT). This task takes approximately 20 minutes.
Rewarded Variant This task is a variant of the above, with an inclusion of a "points possible cue" (2 or 50 points) for 500 ms, and followed by a brief delay (500-1500 ms) prior to the target. The task will be presented in 13 blocks. The first contains only go trials, from which the initial SSD will be calculated. The 12 subsequent blocks each consist of 40 trials; 18 standard go trials, 12 high reward (HR) go trials, 6 standard stop trials, and 4 HR stop trials, presented in random order. The SSD will be determined by a simple staircase-tracking algorithm as described by Logan, in which the SSD is adjusted up or down by 25 ms in order to establish an SSD that produces 50% accuracy of successful performance, with separate staircases calculated for the HR and standard trials. Outcome measures are the standard and high reward GoRTs, the standard and HR SSRTs, and the proportion of responses that would have been unsuccessfully stopped on HR trials if the standard SSD were utilized instead of the HR SSD.
Rewarded Go/NoGo Task In this task, participants are asked to make, or withhold, a button press to one of six stimuli (shapes), that correspond to six trial types: Go (no reward), Go (low reward), Go (high reward), NoGo (no reward), NoGo (low reward), NoGo (high reward). Participants are asked to press a button for Go stimuli and withhold a button press for NoGo stimuli. The ratio of Go stimuli to NoGo stimuli is approximately 15:1. Participants win money for correctly pressing a button for Go stimuli and for withholding a response for NoGo stimuli; conversely, they lose money for failing to respond to a Go stimuli or for failing to withhold a response to NoGo stimuli. There are 1260 trials, and each lasts 1 second. The task takes about 20 minutes to complete. Task may be administered without reward contingencies. In this case, there will only be two trial types: Go and NoGo.
Delay Discounting Task To measure "impulsive choice" the investigators will use a delay-discounting (DD) paradigm101. On each trial, participants make a binary choice between a smaller/sooner and a larger/later reward. The delay of the sooner reward is set as today, 2 weeks, \& 1 month; the delay of the later reward ranges from 2 to 6 weeks after the early reward. The sooner reward is from 1% to 50% less than the late reward (max = $40). Participants will complete approximately 80 trials. Participants are told that two of their choices will be randomly selected for payout at the appropriate time. Outcome variables include the proportion of choices for immediate/sooner rewards, as well as discounting parameter k, obtained by fitting choice data for each subject to a hyperbolic discount function. The task takes approximately 15 minutes to complete.
30 minutes after turning OFF DBS stimulation, participants will either remain in the OFF condition or will have the DBS turned ON, depending on their counter-balanced condition assignment. Subjects will complete the tasks above in the first condition. Following task completion, subjects will have DBS stimulation turned OFF or ON (again, depending on condition assignment). After 30 minutes, participants will complete the same tasks in the second condition. Following retesting, participants that were in the OFF condition will return to ON DBS stimulation.
The investigators will be using the implanted pulse generator to deliver a safe current. Because the investigators are not changing the therapeutic parameters of stimulation, subjects should not experience any changes during the ON condition. Should any discomfort arise in the OFF condition, the subject will be able to terminate the study and return to the ON condition immediately. The computer will register the subject's performance.
Electroencephalography recordings (EEG) will be acquired during performance of the aforementioned tasks. Continuous EEG data will be sampled at a maximum of 1024Hz using a 64-electrode cap. Eye movement artifacts will be assessed using bipolar electrodes.
Patients with just major depressive disorder or obsessive compulsive disorder will also be recruited as a control group for the patients with deep brain stimulation.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Patients with Deep Brain Stimulators | – | –Patients with deep brain stimulation for either major depressive disorder (MDD) or obsessive compulsive disorder (OCD). |
| Patients with MDD or OCD | – | –Patients with MDD or OCD who do not have a deep brain stimulator. |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with Deep Brain Stimulators Patients with Major Depressive Disorder or Obsessive-Compulsive Disorder and no DBS
Key inclusion criteria (4 listed)
- Deep brain stimulator implantation performed at least three months prior to study
- Right-handed (as determined by the Handedness Inventory; Oldfield, 1971)
- Normal or corrected-to normal vision and hearing
- Current diagnosis of MDD or OCD
Key exclusion criteria (11 listed)
- Subjects unable to visualize stimulus objects with correction
- Dementia or other known cognitive deficit
- Clinical history of bipolar disorder
- Current or past psychotic disorder
- Gross structural brain damage
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Impulsive Action
Time frame: 2 hours
As measured by the Go/No Go task
1 secondary outcome
Impulsive Choice
Time frame: 2 hours
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jan 2024.
Related trials for Obsessive Compulsive Disorder
Not yet recruiting
Linear Accelerator Radiosurgical Anterior Capsulotomy With Task-based fMRI Identification of PERSonalized and PrEdictiVE Biomarkers of REsponse in Treatment-Refractory Obsessive-Compulsive Disorder (PERSEVERE Trial)
Treatment-refractory Obsessive-compulsive Disorder (trOCD)
Recruiting
tDCS Associated With Symptom Provocation in the Management of Patients With Resistant Obsessive Compulsive Disorder
Obsessive-Compulsive Disorder
Recruiting
Mindfulness Intervention for Psychological and Family Dynamics in Children With Body-Focused Repetitive Behaviors
Mindfulness Skills, Psychosocial Education
Not yet recruiting
tDCS and Symptom Provocation in Treatment-Resistant OCD
Obsessive - Compulsive Disorder
RecruitingPhase 2
SONATA Dose Duration LIFU for OCD
Obsessive - Compulsive Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Darin D Dougherty, MD principal investigator
Massachusetts General Hospital
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Obsessive Compulsive Disorder and Major Depressive Disorder, run by Massachusetts General Hospital at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 23 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Impulsive Action (time frame: 2 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2024.